Evaluation of Effect of Stopping Mass Azithromycin Treatment after five years

Not Applicable

Recruiting

• Conditions: Eye Diseases; Trachoma

• Registration Number: PACTR201211000437277
• Lead Sponsor: The Carter Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10-18
• Last Update Posted: 2023-05-29

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

All districts in West Amhara that have completed five or more annual rounds of MDA with azithromycin and have been surveyed for impact will be eligible for inclusion into the study.

Exclusion Criteria

Districts where SAFE has been implemented for less than 5 years or where impact evaluations have showed prevalence of TF in children 1-9 years to be below 10% will not be included into the study. In the excluded districts, the SAFE strategy will be continued as per the WHO standards and national guidelines.

Study & Design

• Study Type: Interventional
• Study Design: Not specified